HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Study Suggests Futura’s Drug-Free Erectile Dysfunction Gel Suitable For US OTC Pathway

Executive Summary

The successful completion of a short, non-clinical, human factors study puts Futura Medical's MED3000 erectile dysfunction gel one step closer to OTC device approval in the US.

You may also be interested in...



Government Skepticism And Over Regulation Holding Back Self-Care In France – GSCF Analysis

France's self-medication market lags behind its European rivals. Why is that? A skeptical and over-cautious government and a stifling regulatory system may provide at least part of the answer, the Global Self-Care Federation's recently published Self-Care Readiness Index suggests.  

France ‘Not Receptive’ To Self-Care, But Wellness And E-Commerce Trends Are Driving Change

Regulatory barriers, government conservativism and a generous reimbursement system have all held back the development of France's self-care market. However, executive director of the French self-care industry association, Luc Besançon, thinks that the growing trends for prevention and e-commerce will change this in the future. 

Over The Counter 10 Jan 2022: Greening The Global OTC Industry With Jurate Švarcaite

In this episode, HBW Insight speaks to AESGP director general and GSCF board member Jurate Švarcaite about the GSCF's Charter for Environmentally Sustainable Self-Care, which it describes as the “first industry-wide climate action resolution issued by the consumer health sector.” Švarcaite reveals the story behind the charter and discusses what it aims to achieve, as well as some of the challenges companies face in formulating ambitious, yet concrete and achievable climate action goals.

Topics

UsernamePublicRestriction

Register

RS152081

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel